These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 12735013)

  • 1. [Intravenous coronary thrombolysis on evidence based reperfusion therapy for acute myocardial infarction].
    Nagao K; Kanmatsuse K
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():446-52. PubMed ID: 12735013
    [No Abstract]   [Full Text] [Related]  

  • 2. [Management of acute myocardial infarction: What remains of intravenous thrombolysis?].
    Bonnet JL; Bonnet G
    Presse Med; 2011 Jun; 40(6):611-4. PubMed ID: 21570245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ["Smoker's paradox" and reperfusion's strategy in acute myocardial infarction].
    Addad F; Dridi Z; Jemmali M; Mzoughi K; Hassine M; Ghrissi I; Hamdi S; Mahjoub M; Betbout F; Ben Farhat M; Gamra H
    Ann Cardiol Angeiol (Paris); 2010 Aug; 59(4):183-9. PubMed ID: 20709314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-hospital reperfusion therapy: a strategy to improve therapeutic outcome in patients with ST-elevation myocardial infarction.
    Huber K; De Caterina R; Kristensen SD; Verheugt FW; Montalescot G; Maestro LB; Van de Werf F;
    Eur Heart J; 2005 Oct; 26(19):2063-74. PubMed ID: 16055497
    [No Abstract]   [Full Text] [Related]  

  • 5. Acceptable reperfusion delay to prefer primary angioplasty over fibrin-specific thrombolytic therapy is affected (mainly) by the patient's mortality risk: 1 h does not fit all.
    Tarantini G; Razzolini R; Napodano M; Bilato C; Ramondo A; Iliceto S
    Eur Heart J; 2010 Mar; 31(6):676-83. PubMed ID: 19946106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thrombolytic (fibrinolytic) agents for treatment of ischemic heart disease].
    Nagao K; Kanmatsuse K
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():641-6. PubMed ID: 12735044
    [No Abstract]   [Full Text] [Related]  

  • 7. [The optimal time window for percutaneous coronary intervention in thrombolysis-treated ST-elevation myocardial infarction].
    De Caterina R; Zimarino M
    G Ital Cardiol (Rome); 2010 Sep; 11(9):670-3. PubMed ID: 21348182
    [No Abstract]   [Full Text] [Related]  

  • 8. [Angioplasty compared to thrombolysis as the initial reperfusion therapy in acute myocardial infarction].
    Ugalde H; Ugalde D; Muñoz M
    Rev Med Chil; 2011 Nov; 139(11):1396-402. PubMed ID: 22446643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late myocardial salvage: time to recognize its reality in the reperfusion therapy of acute myocardial infarction.
    Schömig A; Ndrepepa G; Kastrati A
    Eur Heart J; 2006 Aug; 27(16):1900-7. PubMed ID: 16868009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failed thrombolysis after acute myocardial infarction: restoring perfusion beyond TIMI 3 flow.
    Gambhir DS; Sudha R
    Indian Heart J; 2000; 52(4):391-4. PubMed ID: 11084777
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombolysis in the era of intervention.
    Iyengar SS; Godbole GS
    J Assoc Physicians India; 2011 Dec; 59 Suppl():26-30. PubMed ID: 22624278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinolytic therapy: is it a treatment of the past?
    Grines CL; Serruys P; O'Neill WW
    Circulation; 2003 May; 107(20):2538-42. PubMed ID: 12777318
    [No Abstract]   [Full Text] [Related]  

  • 13. [Management of ST-elevation myocardial infarction in 2012].
    Cayla G; Silvain J; Ecollan P; Montalescot G; Collet JP
    Ann Cardiol Angeiol (Paris); 2012 Dec; 61(6):447-52. PubMed ID: 23078947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined reperfusion strategies in ST-segment elevation MI: Rationale and current role.
    Hanna EB; Hennebry TA; Abu-Fadel MS
    Cleve Clin J Med; 2010 Sep; 77(9):629-38. PubMed ID: 20810873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of combined thrombolytic and platelet inhibitor therapy on myocardial and microvascular perfusion.
    de Lemos J
    Md Med; 2001; Suppl():88-9. PubMed ID: 11434069
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombolysis or primary angioplasty? Reperfusion therapy for myocardial infarction in the UK.
    Ratcliffe AT; Pepper C
    Postgrad Med J; 2008 Feb; 84(988):73-7. PubMed ID: 18322126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reperfusion strategies for acute myocardial infarction in the elderly: benefits and risks.
    Mehta RH; Granger CB; Alexander KP; Bossone E; White HD; Sketch MH
    J Am Coll Cardiol; 2005 Feb; 45(4):471-8. PubMed ID: 15708688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Percutaneous transluminal coronary angioplasty (PTCA) for acute myocardial infarction].
    Katoh O; Negoro S; Shinmyoh T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():506-10. PubMed ID: 12735024
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimal reperfusion strategy for acute myocardial infarction.
    Dzielicka E; Swanton H
    Br J Hosp Med (Lond); 2008 Jan; 69(1):18-23. PubMed ID: 18293723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary angioplasty should be first line treatment for acute myocardial infarction: FOR.
    Smith D
    BMJ; 2004 May; 328(7450):1254-6. PubMed ID: 15155508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.